Evidence map›Paper›PMID 21788508›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis.

Lisa Pham, Lisa Christadore, Scott Schaus, Eric D Kolaczyk

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  18. Article
  19. Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.International journal of clinical and experimental pathology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lisa PhamBoston University, Boston, MA 02215, USA.
Lisa Christadore
Scott Schaus
Eric D Kolaczyk
Boston University · US

Funding

Predicting Drug Mechanism via Chemogenomic ProfilingR01GM078987 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KOLACZYK, ERIC D · 2006 to 2010
$1.6M
NIGMS NIH HHS R01 GM078987
6 · The paper itself

Abstract

Understanding the systemic biological pathways and the key cellular mechanisms that dictate disease states, drug response, and altered cellular function poses a significant challenge. Although high-throughput measurement techniques, such as transcriptional profiling, give some insight into the altered state of a cell, they fall far short of providing by themselves a complete picture. Some improvement can be made by using enrichment-based methods to, for example, organize biological data of this sort into collections of dysregulated pathways. However, such methods arguably are still limited to primarily a transcriptional view of the cell. Augmenting these methods still further with networks and additional -omics data has been found to yield pathways that play more fundamental roles. We propose a previously undescribed method for identification of such pathways that takes a more direct approach to the problem than any published to date. Our method, called latent pathway identification analysis (LPIA), looks for statistically significant evidence of dysregulation in a network of pathways constructed in a manner that implicitly links pathways through their common function in the cell. We describe the LPIA methodology and illustrate its effectiveness through analysis of data on (i) metastatic cancer progression, (ii) drug treatment in human lung carcinoma cells, and (iii) diagnosis of type 2 diabetes. With these analyses, we show that LPIA can successfully identify pathways whose perturbations have latent influences on the transcriptionally altered genes.

Indexed as

Gene Expression RegulationGene Regulatory NetworksTranscription, GeneticBenzoquinonesBiological PhenomenaComputational BiologyDiabetes Mellitus, Type 2HSP90 Heat-Shock ProteinsHumansLactams, MacrocyclicMaleNeoplasm MetastasisProstatic NeoplasmsBenzoquinonesgeldanamycinHSP90 Heat-Shock ProteinsLactams, Macrocyclic

Identifiers

PMID21788508
PMCPMC3156179
OpenAlexW2135856405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.